Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -66.0% | -54.6% | 0 / 3 | -10.4% | +0.69 pp | -30.44 pp | +6.0% | 0.34 | 42.89 | 89,5 | −10,4% | 19,9 | −62,2% | 42.89 | 19.13 | +124,2% |
| Pts | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 59.400 (close price on 2026-10-19)EPS (TTM): 1.385
Financial charts
1.Revenue & growth
VND bn89,5Q2/26
1.Revenue & growth
VND bn89,5Q2/26
2.Profit & growth
VND bn19,9Q2/26
3.Profit mix (Penman)
VND bn161Q2/26
4.Margins & cost structure
%26.2%Q2/26
5.Returns & cash cycle
% · days3.3%Q2/26
6.Earnings quality & cash
VND bn203Q2/26
7.Asset structure
VND bn3.566Q2/26
8.Funding & debt health
VND bn · times3.566Q2/26
9.Revenue backlog
VND bn59,0Q2/26
10.Valuation
times · %46,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %179Q2/26
Adjusted EPS growth, latest quarter
-62.6%
Average adjusted EPS growth, 3 quarters
-53.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
1.0%
Source: vnstockData through Q2/26